Cargando…
Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
BACKGROUND: A growing body of evidence showed that gut microbiota dysbiosis might be associated with the pathogenesis of Parkinson’s disease (PD). Microbiota-targeted interventions could play a protective role in PD by regulating the gut microbiota-gut-brain axis. Sodium butyrate (NaB) could improve...
Autores principales: | Zhang, Yi, Xu, Shaoqing, Qian, Yiwei, Mo, Chengjun, Ai, Penghui, Yang, Xiaodong, Xiao, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905700/ https://www.ncbi.nlm.nih.gov/pubmed/36761177 http://dx.doi.org/10.3389/fnagi.2023.1099018 |
Ejemplares similares
-
Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like Mice
por: He, Hanchang, et al.
Publicado: (2020) -
Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson’s disease
por: Zhang, Yi, et al.
Publicado: (2022) -
Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism
por: Wang, Wang, et al.
Publicado: (2022) -
Gut Microbiota Alteration Is Associated With Cognitive Deficits in Genetically Diabetic (Db/db) Mice During Aging
por: Zhang, Jiawei, et al.
Publicado: (2022) -
Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis
por: Dou, Xiujing, et al.
Publicado: (2020)